nach oben

Neurological Sciences

Erschienen in:

12.05.2022 | Original Article

Higher basophil count decreases narcolepsy risk: a Mendelian randomization study

verfasst von: Ang Li, Hao Li, Junyang Xie, Jianlei Xie, Wenjing Liao, Lijuan Song, Xiaowen Zhang

Erschienen in: Neurological Sciences | Ausgabe 9/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Blood cell properties effectively reflect immune status. Basophil and CD8⁺ CD27⁺ T cell levels are correlated with narcolepsy, but their causal association is unclear. This study aims to evaluate the causality between blood cell count and narcolepsy risk at the genetic level.

Methods

Two-sample Mendelian randomization (MR) analyses were performed on 35 published blood cell properties, using genome-wide association study (GWAS) datasets and one published GWAS dataset of narcolepsy, to explore causality between blood cell count and narcolepsy risk. Inverse variance weighted, MR-Egger, and weighted median approaches were employed for the MR analysis, odds ratio (OR) calculations, and heterogeneity tests of single nucleotide polymorphisms were conducted with the TwoSampleMR package in R. Multivariable Mendelian randomization (MVMR) was used to adjust the analysis further and eliminate the mediation effect between exposures.

Results

Basophil counts, total basophil neutrophil counts, total neutrophil eosinophil counts, granulocyte counts, and myeloid white cell counts showed inverse associations with narcolepsy risk based on the two-sample MR analysis. MVMR confirmed that only basophil counts were significantly associated with narcolepsy risk for the blood cell properties tested (OR = 0.23, 95% confidence interval 0.08–0.62; p = 0.004, power = 99.99%). Each standard deviation increase in basophil count (0.03 per nL), compared to the median level (0.04 per nL), decreased narcolepsy risk by 77%.

Conclusion

Higher white blood cell counts, especially basophil counts, are protective factors for narcolepsy. Basophil counts has great potential to be used as a new biomarker to shorten diagnostic delay and to monitor the therapeutic effects of treatments for narcolepsy.

Nur mit Berechtigung zugänglich

Scammell TE (2015) Narcolepsy. N Engl J Med 373(27):2654–2662. https://doi.org/10.1056/NEJMra1500587CrossRefPubMed

Bassetti CLA, Adamantidis A, Burdakov D, Han F, Gay S, Kallweit U et al (2019) Narcolepsy - clinical spectrum, aetiopathophysiology, diagnosis and treatment. Nat Rev Neurol 15(9):519–539. https://doi.org/10.1038/s41582-019-0226-9CrossRefPubMed

Bonvalet M, Ollila HM, AmbatiE A, Mignot, (2017) Autoimmunity in narcolepsy. Curr Opin Pulm Med 23(6):522–529. https://doi.org/10.1097/MCP.0000000000000426CrossRefPubMedPubMedCentral

Hor H, Kutalik Z, Dauvilliers Y, Valsesia A, Lammers GJ, Donjacour CE et al (2010) Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy. Nat Genet 42(9):786–789. https://doi.org/10.1038/ng.647CrossRefPubMed

Mignot E (1998) Genetic and familial aspects of narcolepsy. Neurology 50(2 Suppl 1):S16-22. https://doi.org/10.1212/wnl.50.2_suppl_1.s16CrossRefPubMed

Partinen M, Hublin C, Kaprio J, KoskenvuoC M, Guilleminault, (1994) Twin studies in narcolepsy. Sleep 17(8 Suppl):S13–S16. https://doi.org/10.1093/sleep/17.suppl_8.s13CrossRefPubMed

Han F, Lin L, Warby SC, Faraco J, Li J, Dong SX et al (2011) Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol 70(3):410–417. https://doi.org/10.1002/ana.22587CrossRefPubMed

Duffy J, Weintraub E, Vellozzi C, DeStefanoD F, Safety V (2014) Narcolepsy and influenza A(H1N1) pandemic 2009 vaccination in the United States. Neurology 83(20):1823–1830. https://doi.org/10.1212/WNL.0000000000000987CrossRefPubMed

Aran A, Lin L, Nevsimalova S, Plazzi G, Hong SC, Weiner K et al (2009) Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset. Sleep 32(8):979–983. https://doi.org/10.1093/sleep/32.8.979CrossRefPubMedPubMedCentral

10.

Thorpy MJACK (2014) Delayed diagnosis of narcolepsy: characterization and impact. Sleep Med 15(5):502–507. https://doi.org/10.1016/j.sleep.2014.01.015CrossRefPubMed

11.

Notta F, Zandi S, Takayama N, Dobson S, Gan OI, Wilson G et al (2016) Distinct routes of lineage development reshape the human blood hierarchy across ontogeny. Science. 351(6269):aab2116. https://doi.org/10.1126/science.aab2116CrossRefPubMed

12.

Vasquez LJ, Mann AL, ChenN L, Soranzo, (2016) From GWAS to function: lessons from blood cells. ISBT Sci Ser 11(Suppl 1):211–219. https://doi.org/10.1111/voxs.12217CrossRefPubMed

13.

Astle WJ, Elding H, Jiang T, Allen D, Ruklisa D, Mann AL et al (2016) The allelic landscape of human blood cell trait variation and links to common complex disease. Cell. 167(5):1415-1429 e19. https://doi.org/10.1016/j.cell.2016.10.042CrossRefPubMedPubMedCentral

14.

Lind A, Salami F, Landtblom AM, Palm L, Lernmark A, Adolfsson J et al (2021) Immunocyte single cell analysis of vaccine-induced narcolepsy. Eur J Immunol 51(1):247–249. https://doi.org/10.1002/eji.202048633CrossRefPubMed

15.

Faraco J, Lin L, Kornum BR, Kenny EE, Trynka G, Einen M et al (2013) ImmunoChip study implicates antigen presentation to T cells in narcolepsy. PLoS Genet 9(2):e1003270. https://doi.org/10.1371/journal.pgen.1003270CrossRefPubMedPubMedCentral

16.

Burgess S, A. ButterworthS.G. Thompson, (2013) Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol 37(7):658–665. https://doi.org/10.1002/gepi.21758CrossRefPubMedPubMedCentral

17.

Bowden J, Smith GD, HaycockS PC, Burgess, (2016) Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 40(4):304–314. https://doi.org/10.1002/gepi.21965CrossRefPubMedPubMedCentral

18.

Bowden J, Davey SmithS G, Burgess, (2015) Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44(2):512–525. https://doi.org/10.1093/ije/dyv080CrossRefPubMedPubMedCentral

19.

Verbanck M, Chen CY, NealeR B, Do, (2018) Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 50(5):693–698. https://doi.org/10.1038/s41588-018-0099-7CrossRefPubMedPubMedCentral

20.

Hemani, G., J. Zheng, B. Elsworth, K.H. Wade, V. Haberland, D. Baird, et al. (2018) The MR-Base platform supports systematic causal inference across the human phenome. Elife. 7. https://doi.org/10.7554/eLife.34408

21.

Burgess S (2014) Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome. Int J Epidemiol 43(3):922–929. https://doi.org/10.1093/ije/dyu005CrossRefPubMedPubMedCentral

22.

Maski K, Steinhart E, Williams D, Scammell T, Flygare J, McCleary K et al (2017) Listening to the patient voice in narcolepsy: diagnostic delay, disease burden, and treatment efficacy. J Clin Sleep Med 13(3):419–425. https://doi.org/10.5664/jcsm.6494CrossRefPubMedPubMedCentral

23.

Gerashchenko D, Murillo-Rodriguez E, Lin L, Xu M, Hallett L, Nishino S et al (2003) Relationship between CSF hypocretin levels and hypocretin neuronal loss. Exp Neurol 184(2):1010–1016. https://doi.org/10.1016/S0014-4886(03)00388-1CrossRefPubMed

24.

Thorpy MJYD (2015) Clinical and practical considerations in the pharmacologic management of narcolepsy. Sleep Med 16(1):9–18. https://doi.org/10.1016/j.sleep.2014.10.002CrossRefPubMed

25.

Gupta V, G.K. WaliaM.P. Sachdeva, (2017) ‘Mendelian randomization’: an approach for exploring causal relations in epidemiology. Public Health 145:113–119. https://doi.org/10.1016/j.puhe.2016.12.033CrossRefPubMed

26.

Lawlor DA, Harbord RM, Sterne JA, TimpsonG N, Smith D (2008) Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 27(8):1133–1163. https://doi.org/10.1002/sim.3034CrossRefPubMed

27.

Bowden JMVH (2019) Meta-analysis and Mendelian randomization: a review. Res Synth Methods 10(4):486–496. https://doi.org/10.1002/jrsm.1346CrossRefPubMedPubMedCentral

28.

Borzova E (2020) The absolute basophil count. Methods Mol Biol 2163:109–124. https://doi.org/10.1007/978-1-0716-0696-4_9CrossRefPubMed

29.

Olivera AJR (2020) Paradigm shifts in mast cell and basophil biology and function: an emerging view of immune regulation in health and disease. Methods Mol Biol 2163:3–31. https://doi.org/10.1007/978-1-0716-0696-4_1CrossRefPubMed

30.

Liang P, Tang Y, Fu S, Lv J, Liu B, Feng M et al (2015) Basophil count, a marker for disease activity in systemic lupus erythematosus. Clin Rheumatol 34(5):891–896. https://doi.org/10.1007/s10067-014-2822-9CrossRefPubMed

31.

Yamaga S, Yanase Y, Ishii K, Ohshimo S, ShimeM N, Hide, (2020) Decreased intracellular histamine concentration and basophil activation in anaphylaxis. Allergol Int 69(1):78–83. https://doi.org/10.1016/j.alit.2019.05.009CrossRefPubMed

32.

Bentham J, Morris DL, Graham DSC, Pinder CL, Tombleson P, Behrens TW et al (2015) Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat Genet 47(12):1457–1464. https://doi.org/10.1038/ng.3434CrossRefPubMedPubMedCentral

33.

Hom G, Graham RR, Modrek B, Taylor KE, Ortmann W, Garnier S et al (2008) Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 358(9):900–909. https://doi.org/10.1056/NEJMoa0707865CrossRefPubMed

34.

Giannoccaro MP, Liguori R, PlazziF G, Pizza, (2021) Reviewing the clinical implications of treating narcolepsy as an autoimmune disorder. Nat Sci Sleep 13:557–577. https://doi.org/10.2147/NSS.S275931CrossRefPubMedPubMedCentral

35.

Marques P, de Vries F, Dekkers OM, van Furth WR, Korbonits M, Biermasz NR et al (2021) Pre-operative serum inflammation-based scores in patients with pituitary adenomas. Pituitary 24(3):334–350. https://doi.org/10.1007/s11102-020-01112-5CrossRefPubMed

Titel: Higher basophil count decreases narcolepsy risk: a Mendelian randomization study
verfasst von: Ang Li
Hao Li
Junyang Xie
Jianlei Xie
Wenjing Liao
Lijuan Song
Xiaowen Zhang
Publikationsdatum: 12.05.2022
Verlag: Springer International Publishing
Erschienen in: Neurological Sciences / Ausgabe 9/2022
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-022-06123-7

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2022

The association between onabotulinumtoxinA and anti-CGRP monoclonal antibodies: a reliable option for the optimal treatment of chronic migraine

First case report of anti-AMPA receptor encephalitis presenting with features of parkinsonism

Multiple sclerosis in patients with hereditary spastic paraplegia: a case report and systematic review

The prognostic value of the preoperative inflammatory index on the survival of glioblastoma patients

The safety of acupuncture for migraine prevention during pregnancy